AGTC - Applied Genetic Technologies Corporation - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

12.2M

Cash

34.24M

Avg Qtr Burn

-16.46M

Short % of Float

2.05%

Insider Ownership

0.86%

Institutional Own.

29.93%

Qtr Updated

09/30/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AGTC-401 Details Genetic disorder, Achromatopsia, Solid tumor/s, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AGTC-501 Details Genetic disorder, X-linked retinitis pigmentosa, Vision loss	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AGTC-402 Details Genetic disorder, Achromatopsia, Multiple myeloma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.